FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/03/2023
Voltar para busca
Dado oficial do USPTO
GALEXI
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
06/03/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42
Data de depósito
11/06/2021
Data de registro
25/10/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/10/2022
Última transação
25/10/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
82
Localização do titular
AU
Examinador
HUSSAIN, TASNEEM
Unidade examinadora
M90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Agilex Biolabs Pty Ltd
Representantes
David L. May Nixon Peabody LLP
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Advisory services relating to biochemistry; advisory services relating to pharmacology; advisory services relating to pharmaceutical product testing; advisory services relating to science in the field of bioanalytics; advisory services relating to scientific research in the field of bioanalytics; analysis of materialsbioanalytical services; analytical scientific laboratory services in the field of bioanalytics; biochemistry research services; biochemistry services; biological research; biotechnological research; biotechnology research; biotechnology testing; development of computer systems for the processing of data in the field of bioanalytics; development of chemical production testing methods for medical clinical trials; scientific research in the nature of conducting medical clinical trials for others; consultancy pertaining to pharmacology; laboratory analysis in the field of bioanalytics; laboratory research in the field of bioanalytics; medical research laboratory services; medical laboratory services being scientific research or analysis; laboratory testing services in the field of bioanalytics; pharmaceutical research services; preparation of reports relating to scientific research in the field of bioanalytics; provision of information relating to scientific research in the field of bioanalytics; pharmaceutical product quality testing; research laboratories in the field of bioanalytics; scientific research relating to data processingresearch on development of data processing programs by order of third parties; research relating to medicine; research relating to pharmaceuticals; scientific and technical analysis in the field of bioanalytics; scientific research consultancy in the field of bioanalytics; scientific laboratory services in the field of bioanalytics; scientific research in the field of bioanalytics; scientific testing services in the field of bioanalytics; services for assessing the safety of pharmaceuticals; testing of pharmaceutical products
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/02/2023
FIMP
FINAL DISPOSITION PROCESSED
10/02/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
25/01/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
25/10/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
25/10/2022
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
18/09/2022
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
06/06/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/05/2022
PUBO
PUBLISHED FOR OPPOSITION
10/05/2022
GPNX
NOTIFICATION PROCESSED BY IB
09/05/2022
RFNT
REFUSAL PROCESSED BY IB
24/04/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/04/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
20/04/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/04/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/04/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
05/04/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/04/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
05/04/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/04/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/04/2022
RFRR
REFUSAL PROCESSED BY MPU
31/03/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
30/03/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
30/03/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
30/03/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
30/03/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
30/03/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
30/03/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/03/2022
CNRT
NON-FINAL ACTION WRITTEN
03/03/2022
DOCK
ASSIGNED TO EXAMINER
03/03/2022
MAFR
APPLICATION FILING RECEIPT MAILED
20/07/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/07/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/07/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GALEXI ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.